2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank
h h h
100 correct answeard
h h
1. Ahnursinghinstructorhishpreparinghahteachinghplanhforhahgrouphofhnursinghstudentshabouthph
armacology.hWhenhdescribinghthishtopic,hthehinstructorhwouldhfocushthehdiscussionhonhwhi
chhofhthehfollowinghashanhessentialhaspect?
A) Drughname
B) Drughclass
C) Drughaction
D) Drughsourceh
Ans:h ChFeedbac
k:
Pharmacologyhishthehstudyhofhdrugshandhtheirhactionhonhlivinghorganisms.hThus,hanhessenti
alhaspecth ofhpharmacologyhishdrughaction.hAnhunderstandinghofhthehdrughname,hdrughclass,ha
ndhdrughsourcehishimportant,hbuththehmosthcriticalhaspecthrelatedhtohpharmacologyhishhowhth
ehdrughactshinhthehbody.
2. Ahnursinghstudenthishpreparinghtohadministerhahprescribedhdrughtohahpatient.hThehstudenthre
viewshinformationhabouththehdrughandhitshactions.hWhichhofhthehfollowinghwouldhbehthehbes
thchoicehforhobtaininghthishinformation?hSelecth allhthath apply.
A) Nursinghinstructor
B) Nursehassignedhtohthehpatient
C) Clinicalhdrughreference
D) Prescribinghhealthhcarehprovider
E) Clinicalhpharmacisth
Ans:h C,hE
Feedback:
Althoughhthehnursinghstudenthcanhaskhthehnursinghinstructor,hthehnursehassignedhtohthehpati
ent,handhthehprescribinghhealthhcarehproviderh forhinformationhabouththehdrug,hthehbesthchoic
eshforhdrughinformationhwouldhincludehanhappropriatehdrughreferencehandhthehclinicalhphar
macist.
3. Whenhdescribinghthehvarioushtypeshofhmedicationshtohahgrouphofhnursinghstudents,hahn
ursinghinstructorhwouldhidentifyhwhichhofhthehfollowinghashahsourcehforhderivinghme
dications?hSelecth allhthathapply.
A) Plants
B) Synthetichsources
C) Mold
D) Minerals
E) AnimalshAn
s:hA,hB,hC,hD,hEhFe
edback:
Medicationsharehderivedhfromhnaturalhsources,hforhexample,hplants,hmolds,hminerals,handhanima
ls,h ashwellhashcreatedhsyntheticallyhinhah laboratory.
Pageh 1
,2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeardh
4. Whichhofhthehfollowinghnameshmayhbehassignedhtohahdrughduringhthehprocesshofhd
evelopment?hSelecth allhthath apply.
A) Chemicalhname
B) Officialhname
C) Pharmacologichname
D) Tradehname
E) Nonproprietaryhnameh
Ans:h A,hB,hD,hEhFeedback
:
Throughouththehprocesshofhdevelopment,hdrugshmayhhavehseveralhnameshassignedhtohthem
hincludinghahchemicalhname,hahgenerich(nonproprietary)hname,hanhofficialhname,handhahtrade
horhbrandh name.
5. Ahdrughmayhbehclassifiedhbyhwhichhofhthehfollowing?hSelecth allhthathapply.
A) Thehchemicalhtypehofhthehdrug'shactiveh ingredient
B) Thehwayhthehdrughishusedhtohtreath ahspecifichcondition
C) Thehgenerichnamehofhthehdrug
D) Thehtradehnamehofhthehdrug
E) Thehnonproprietaryhnamehofhthehdrugh
Ans:h A,hB
Feedback:
Ahdrughmayhbehclassifiedhbyhthehchemicalhtypehofhthehactivehingredienth orhbyhthehwayhith ishu
sedhtohtreathahparticularhcondition.hGeneric,htrade,handhnonproprietaryhreferhtohhowhahdrughi
shnamed.
6. Ahgrouphofhnursinghstudentsharehreviewinghinformationhabouththehprocesshofhdrughdeve
lopmenthinhthehUnitedhStates.hThehstudentshdemonstratehunderstandinghofhthishprocessh
whenhtheyhidentifyhthathwhichhofhthehfollowinghcategoriesharehassignedhbyhthehFoodhand
hDrughAdministrationhtohnewlyhapprovedh drugs?hSelecth allhthath apply.
A) Metabolite
B) Noncontrolledhsubstance
C) Prescription
D) Nonprescription
E) Controlledhsubstanceh
Ans:h C,hD,hE
Feedback:
Oncehdrugsharehapprovedhforhuse,hthehFDAhassignshthehdrughtohonehofhthehfollowinghcateg
ories:hprescription,hnonprescription,horhcontrolledhsubstance.hMetabolitehrefershtohthehinact
iveh formhofhthehdrug.hNoncontrolledhsubstanceh ishahtermhthathishnothused.
Pageh 2
,2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeard h
7. Whichhofhthehfollowinghwouldhbehmosthimportanthforhthehnursehtohdohtohensurehthehsafehu
sehofhprescriptionhdrugshinhthehinstitutionalhsetting?hSelecth allhthath apply.
A) Administeringhdrugs
B) Monitoringhclientshforhdrugheffects
C) Prescribinghdrugs
D) Evaluatinghclientshforhtoxicheffects
E) Educatinghclients/caregivershabouthdrugsh
Ans:h A,hB,hD,h E
Feedback:
Inhthehinstitutionalhsetting,hthehnurse'shrolehtohensurehsafehusehofhprescriptionhdrugshinclude
shadministeringhdrugs,hmonitoringhdrugheffects,hevaluatinghforhtoxicheffects,handheducatingh
clientshandhcaregivershabouth drugs.
8. Thehnursehishhelpinghahclienthreviewhahprescriptionhfromhthehhealthhcarehprovider.hWhenhe
xamininghthehprescription,hwhichhofhthehfollowinghwouldhthehnursehexpecthtohfindhdocu
mented?hSelecth allhthath apply.
A) Namehofhthehdrug
B) Dosagehofhthehdrug
C) Routehofhdrughadministration
D) Timeshofhdrughadministration
E) Licensedhprescriber'shsignatureh
Ans:h A,hB,hC,hD,hE
Feedback:
Thehprescriptionhmusthcontainhthehclient'shname,hthehnamehofhthehdrug,hthehdosage,hthehmet
hodhandhtimeshofhadministration,handhthehsignaturehofhthehlicensedhhealthhcarehproviderhpr
escribinghthehdrug.
9. Afterhteachinghahgrouphofhnursinghstudentshabouthnonprescriptionhdrugs,hthehnursinghinstr
uctorhdetermineshthaththehteachinghwashsuccessfulhwhenhthehstudentshidentifyhwhichhofhthe
hfollowing?hSelecth allhthath apply.
A) Theyhrequirehahlicensedhhealthhcarehprovider'shsignature.
B) Theyharehreferredhtohashover-the-counterhdrugs.
C) Theyhcanhbehtakenhwithouthriskhtohthehclient.
D) Theyhhavehcertainhlabelinghrequirements.
E) Theyhshouldh behtakenhonlyhashdirectedhonhthehlabel.h
Ans:h B,hD,hE
Feedback:
Nonprescriptionhdrugsharehoftenhreferredhtohashover-the-
counterh(OTC)hdrugs.hTheyhdohnothrequirehahprescriptionh(ahlicensedhhealthhcarehprovider'
shsignature)hbuthdohnothcomehwithouthriskhtohthehclient.hThehfederalhgovernmenthhashimpos
edhlabelinghrequirementshofhOTChdrugshandhtheyhshouldhonlyhbehtakenhashdirectedhonhthehl
abelhunlesshunderhthehsupervisionhofhahhealthhcarehprovider.
Pageh 3
, 2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeard h
10. AhnursinghstudenthishreviewinghinformationhabouththehControlledhSubstanceshActhofh19
70.hThehstudenthwouldhexpecthtohfindhwhichhofhthehfollowinghashbeinghregulatedhforhdru
gshclassifiedhashcontrolledhsubstances?hSelecth allhthath apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensingh
Ans:h A,hC,hEhFee
dback:
ThehControlledhSubstanceshActhofh1970hregulateshthehmanufacture,hdistribution,handhdispe
nsinghofhdrugshclassifiedhashcontrolledhsubstances.hEliminationhrefershtohthehexcretionhofhd
rugshfromhthehbody,hahpharmacokinetichactivity.hThehacthdoeshnoth addresshformulationhofhth
ehdrug.
11. WhenhreviewinghinformationhabouththehOrphanhDrughProgram,hwhichhofhthehfollowingh
wouldhthehnursehexpecthtohfind?hSelecth allhthath apply.
A) Thehprogramhencourageshthehdevelopmenth andhmarketinghofhproductshtohtreathrarehd
iseases.
B) Thehprogramhgrantshprovisionalhapprovalhwithhahwrittenh commitmenth fromhthehd
rughcompanyhtohformallyhdemonstratehclienth benefits.
C) Thehprogramhprovideshforhincentives,hsuchhashresearchhgrants,hprotocolhassistance,ha
ndhspecialhtaxhcredits,htoh develophproductshtohtreathrarehdiseases.
D) Thehprogramhgrantsh7hyearshofhexclusivehmarketinghrightshtohthehmanufacturerhifha
pproved.
E) Thehprogramhaccelerateshapprovalhofhdrugshbasedhonhpreliminaryhevidencehbeforehf
ormalhdemonstrationhofhclienth benefits.
Ans:h A,hC,hD
Feedback:
ThehOrphanhDrughProgramhencourageshthehdevelopmenth andhmarketinghofhproductshusedht
ohtreathrarehdiseases.hThehprogramhprovideshincentiveshtohencouragehmanufacturershtohdev
elophorphanhdrugs,handhifhapproved,hthehmanufacturerhhash7hyearshofhexclusivehmarketingh
rights.hAcceleratedhprogramshinvolvehprovisionalhapprovalhandhapprovalhbasedhonhprelimi
naryhevidence.
Pageh 4
h h h h
armacology 11th edition testbank
h h h
100 correct answeard
h h
1. Ahnursinghinstructorhishpreparinghahteachinghplanhforhahgrouphofhnursinghstudentshabouthph
armacology.hWhenhdescribinghthishtopic,hthehinstructorhwouldhfocushthehdiscussionhonhwhi
chhofhthehfollowinghashanhessentialhaspect?
A) Drughname
B) Drughclass
C) Drughaction
D) Drughsourceh
Ans:h ChFeedbac
k:
Pharmacologyhishthehstudyhofhdrugshandhtheirhactionhonhlivinghorganisms.hThus,hanhessenti
alhaspecth ofhpharmacologyhishdrughaction.hAnhunderstandinghofhthehdrughname,hdrughclass,ha
ndhdrughsourcehishimportant,hbuththehmosthcriticalhaspecthrelatedhtohpharmacologyhishhowhth
ehdrughactshinhthehbody.
2. Ahnursinghstudenthishpreparinghtohadministerhahprescribedhdrughtohahpatient.hThehstudenthre
viewshinformationhabouththehdrughandhitshactions.hWhichhofhthehfollowinghwouldhbehthehbes
thchoicehforhobtaininghthishinformation?hSelecth allhthath apply.
A) Nursinghinstructor
B) Nursehassignedhtohthehpatient
C) Clinicalhdrughreference
D) Prescribinghhealthhcarehprovider
E) Clinicalhpharmacisth
Ans:h C,hE
Feedback:
Althoughhthehnursinghstudenthcanhaskhthehnursinghinstructor,hthehnursehassignedhtohthehpati
ent,handhthehprescribinghhealthhcarehproviderh forhinformationhabouththehdrug,hthehbesthchoic
eshforhdrughinformationhwouldhincludehanhappropriatehdrughreferencehandhthehclinicalhphar
macist.
3. Whenhdescribinghthehvarioushtypeshofhmedicationshtohahgrouphofhnursinghstudents,hahn
ursinghinstructorhwouldhidentifyhwhichhofhthehfollowinghashahsourcehforhderivinghme
dications?hSelecth allhthathapply.
A) Plants
B) Synthetichsources
C) Mold
D) Minerals
E) AnimalshAn
s:hA,hB,hC,hD,hEhFe
edback:
Medicationsharehderivedhfromhnaturalhsources,hforhexample,hplants,hmolds,hminerals,handhanima
ls,h ashwellhashcreatedhsyntheticallyhinhah laboratory.
Pageh 1
,2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeardh
4. Whichhofhthehfollowinghnameshmayhbehassignedhtohahdrughduringhthehprocesshofhd
evelopment?hSelecth allhthath apply.
A) Chemicalhname
B) Officialhname
C) Pharmacologichname
D) Tradehname
E) Nonproprietaryhnameh
Ans:h A,hB,hD,hEhFeedback
:
Throughouththehprocesshofhdevelopment,hdrugshmayhhavehseveralhnameshassignedhtohthem
hincludinghahchemicalhname,hahgenerich(nonproprietary)hname,hanhofficialhname,handhahtrade
horhbrandh name.
5. Ahdrughmayhbehclassifiedhbyhwhichhofhthehfollowing?hSelecth allhthathapply.
A) Thehchemicalhtypehofhthehdrug'shactiveh ingredient
B) Thehwayhthehdrughishusedhtohtreath ahspecifichcondition
C) Thehgenerichnamehofhthehdrug
D) Thehtradehnamehofhthehdrug
E) Thehnonproprietaryhnamehofhthehdrugh
Ans:h A,hB
Feedback:
Ahdrughmayhbehclassifiedhbyhthehchemicalhtypehofhthehactivehingredienth orhbyhthehwayhith ishu
sedhtohtreathahparticularhcondition.hGeneric,htrade,handhnonproprietaryhreferhtohhowhahdrughi
shnamed.
6. Ahgrouphofhnursinghstudentsharehreviewinghinformationhabouththehprocesshofhdrughdeve
lopmenthinhthehUnitedhStates.hThehstudentshdemonstratehunderstandinghofhthishprocessh
whenhtheyhidentifyhthathwhichhofhthehfollowinghcategoriesharehassignedhbyhthehFoodhand
hDrughAdministrationhtohnewlyhapprovedh drugs?hSelecth allhthath apply.
A) Metabolite
B) Noncontrolledhsubstance
C) Prescription
D) Nonprescription
E) Controlledhsubstanceh
Ans:h C,hD,hE
Feedback:
Oncehdrugsharehapprovedhforhuse,hthehFDAhassignshthehdrughtohonehofhthehfollowinghcateg
ories:hprescription,hnonprescription,horhcontrolledhsubstance.hMetabolitehrefershtohthehinact
iveh formhofhthehdrug.hNoncontrolledhsubstanceh ishahtermhthathishnothused.
Pageh 2
,2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeard h
7. Whichhofhthehfollowinghwouldhbehmosthimportanthforhthehnursehtohdohtohensurehthehsafehu
sehofhprescriptionhdrugshinhthehinstitutionalhsetting?hSelecth allhthath apply.
A) Administeringhdrugs
B) Monitoringhclientshforhdrugheffects
C) Prescribinghdrugs
D) Evaluatinghclientshforhtoxicheffects
E) Educatinghclients/caregivershabouthdrugsh
Ans:h A,hB,hD,h E
Feedback:
Inhthehinstitutionalhsetting,hthehnurse'shrolehtohensurehsafehusehofhprescriptionhdrugshinclude
shadministeringhdrugs,hmonitoringhdrugheffects,hevaluatinghforhtoxicheffects,handheducatingh
clientshandhcaregivershabouth drugs.
8. Thehnursehishhelpinghahclienthreviewhahprescriptionhfromhthehhealthhcarehprovider.hWhenhe
xamininghthehprescription,hwhichhofhthehfollowinghwouldhthehnursehexpecthtohfindhdocu
mented?hSelecth allhthath apply.
A) Namehofhthehdrug
B) Dosagehofhthehdrug
C) Routehofhdrughadministration
D) Timeshofhdrughadministration
E) Licensedhprescriber'shsignatureh
Ans:h A,hB,hC,hD,hE
Feedback:
Thehprescriptionhmusthcontainhthehclient'shname,hthehnamehofhthehdrug,hthehdosage,hthehmet
hodhandhtimeshofhadministration,handhthehsignaturehofhthehlicensedhhealthhcarehproviderhpr
escribinghthehdrug.
9. Afterhteachinghahgrouphofhnursinghstudentshabouthnonprescriptionhdrugs,hthehnursinghinstr
uctorhdetermineshthaththehteachinghwashsuccessfulhwhenhthehstudentshidentifyhwhichhofhthe
hfollowing?hSelecth allhthath apply.
A) Theyhrequirehahlicensedhhealthhcarehprovider'shsignature.
B) Theyharehreferredhtohashover-the-counterhdrugs.
C) Theyhcanhbehtakenhwithouthriskhtohthehclient.
D) Theyhhavehcertainhlabelinghrequirements.
E) Theyhshouldh behtakenhonlyhashdirectedhonhthehlabel.h
Ans:h B,hD,hE
Feedback:
Nonprescriptionhdrugsharehoftenhreferredhtohashover-the-
counterh(OTC)hdrugs.hTheyhdohnothrequirehahprescriptionh(ahlicensedhhealthhcarehprovider'
shsignature)hbuthdohnothcomehwithouthriskhtohthehclient.hThehfederalhgovernmenthhashimpos
edhlabelinghrequirementshofhOTChdrugshandhtheyhshouldhonlyhbehtakenhashdirectedhonhthehl
abelhunlesshunderhthehsupervisionhofhahhealthhcarehprovider.
Pageh 3
, 2021 Roachs Introductory Clinical Ph
h h h h
armacology 11th edition testbank100
h h h h h
correct answeard h
10. AhnursinghstudenthishreviewinghinformationhabouththehControlledhSubstanceshActhofh19
70.hThehstudenthwouldhexpecthtohfindhwhichhofhthehfollowinghashbeinghregulatedhforhdru
gshclassifiedhashcontrolledhsubstances?hSelecth allhthath apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensingh
Ans:h A,hC,hEhFee
dback:
ThehControlledhSubstanceshActhofh1970hregulateshthehmanufacture,hdistribution,handhdispe
nsinghofhdrugshclassifiedhashcontrolledhsubstances.hEliminationhrefershtohthehexcretionhofhd
rugshfromhthehbody,hahpharmacokinetichactivity.hThehacthdoeshnoth addresshformulationhofhth
ehdrug.
11. WhenhreviewinghinformationhabouththehOrphanhDrughProgram,hwhichhofhthehfollowingh
wouldhthehnursehexpecthtohfind?hSelecth allhthath apply.
A) Thehprogramhencourageshthehdevelopmenth andhmarketinghofhproductshtohtreathrarehd
iseases.
B) Thehprogramhgrantshprovisionalhapprovalhwithhahwrittenh commitmenth fromhthehd
rughcompanyhtohformallyhdemonstratehclienth benefits.
C) Thehprogramhprovideshforhincentives,hsuchhashresearchhgrants,hprotocolhassistance,ha
ndhspecialhtaxhcredits,htoh develophproductshtohtreathrarehdiseases.
D) Thehprogramhgrantsh7hyearshofhexclusivehmarketinghrightshtohthehmanufacturerhifha
pproved.
E) Thehprogramhaccelerateshapprovalhofhdrugshbasedhonhpreliminaryhevidencehbeforehf
ormalhdemonstrationhofhclienth benefits.
Ans:h A,hC,hD
Feedback:
ThehOrphanhDrughProgramhencourageshthehdevelopmenth andhmarketinghofhproductshusedht
ohtreathrarehdiseases.hThehprogramhprovideshincentiveshtohencouragehmanufacturershtohdev
elophorphanhdrugs,handhifhapproved,hthehmanufacturerhhash7hyearshofhexclusivehmarketingh
rights.hAcceleratedhprogramshinvolvehprovisionalhapprovalhandhapprovalhbasedhonhprelimi
naryhevidence.
Pageh 4
